Home › Funds › ORBIMED ADVISORS LLC › NTRA
ORBIMED ADVISORS LLC position in NTRA
NATERA INC · Health Care
ORBIMED ADVISORS LLC reported holding 262,000 shares of NTRA (NATERA INC) in its Q2 2026 13F filing — a position valued at US$71.1M, representing 1.43% of its reported portfolio and ranking #18 among its reported holdings. ORBIMED ADVISORS LLC has disclosed NTRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's NTRA position evolved
ORBIMED ADVISORS LLC first disclosed a stake in NTRA in Q3 2023 at 920,581 shares (US$40.7M). The position peaked in Q2 2025 at 593,434 shares, worth US$100.3M. Across 12 filings, ORBIMED ADVISORS LLC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 262,000 shares valued at US$71.1M. Notable position changes include a 40% trim in Q4 2024 (shares fell 10% over the following quarter), a 32% increase in Q1 2025 (shares rose 19% over the following quarter), a 28% trim in Q1 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 920.58K | $40.74M | New |
| Q4 2023 | 954.48K | $59.79M | Add |
| Q1 2024 | 899.43K | $82.26M | Reduce |
| Q2 2024 | 687.50K | $74.45M | Reduce |
| Q3 2024 | 687.50K | $87.28M | Hold |
| Q4 2024 | 413.00K | $65.38M | Reduce |
| Q1 2025 | 547.00K | $77.35M | Add |
| Q2 2025 | 593.43K | $100.25M | Add |
| Q3 2025 | 429.30K | $69.10M | Reduce |
| Q4 2025 | 365.80K | $83.80M | Reduce |
| Q1 2026 | 262.00K | $52.40M | Reduce |
| Q2 2026 | 262.00K | $71.12M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NTRA and 13F data
NTRA (NATERA INC) is a Health Care company. 52 other funds we track also report a position in NTRA — the largest reported positions include JPMorgan Chase & Co (US$3.51B), Duquesne Family Office LLC (US$864.9M), Castle Hook Partners LP (US$704.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NTRA
- JPMorgan Chase & Co 12.87M sh · $3.51B · Q2 2026
- Duquesne Family Office LLC 3.19M sh · $864.92M · Q2 2026
- Castle Hook Partners LP 2.60M sh · $704.76M · Q2 2026
- Coatue Management 2.51M sh · $680.01M · Q2 2026
- COATUE MANAGEMENT LLC 2.51M sh · $680.01M · Q2 2026
- Farallon Capital Management 2.22M sh · $602.18M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.22M sh · $602.18M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 1.78M sh · $482.64M · Q2 2026
- Sofinnova Investments, Inc. 1.55M sh · $420.82M · Q2 2026
- Maverick Capital 1.36M sh · $368.27M · Q2 2026
- MAVERICK CAPITAL LTD 1.36M sh · $368.27M · Q2 2026
- D. E. Shaw & Co., Inc. 1.28M sh · $347.25M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held NTRA?
ORBIMED ADVISORS LLC has disclosed NTRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ORBIMED ADVISORS LLC's current position in NTRA?
As of Q2 2026, ORBIMED ADVISORS LLC holds 262.00K shares of NTRA (NATERA INC), valued at $71.12M, representing 1.43% of its reported portfolio and ranking #18.
Has ORBIMED ADVISORS LLC been buying or selling NTRA?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC held unchanged its position in NTRA. The position peaked in Q2 2025 at 593.43K shares.
Which other funds hold NTRA?
Other major institutional holders of NTRA include JPMorgan Chase & Co, Duquesne Family Office LLC, Castle Hook Partners LP, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.